BASSLER BONNIE L 1683607 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-26 | 2023-06-23 | 2023-06-23 | 4 | Bassler Bonnie L | DIRECTOR | acq | 7747.0 | 18.2 | 0.17 | 0.0 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code A | 42577.0 | 448.2 (RPRX) |
| 2023-06-30 | 2023-06-30 | 2023-06-30 | 4 | Bassler Bonnie L | DIRECTOR | acq | 1208.0 | 2.76 | 0.03 | 31.03 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code A | 43785.0 | 448.2 (RPRX) |
| 2023-08-11 | 2023-08-10 | 2023-08-10 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 853.0 | 40.62 | 0.08 | 789.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1247.0 | 106.74 (REGN) |
| 2023-08-11 | 2023-08-10 | 2023-08-10 | 4 | Bassler Bonnie L | DIRECTOR | acq | 853.0 | 40.62 | 0.08 | 391.92 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 2100.0 | 106.74 (REGN) |
| 2023-08-23 | 2023-08-21 | 2023-08-21 | 4 | Bassler Bonnie L | DIRECTOR | acq | 853.0 | 40.62 | 0.08 | 391.92 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 2100.0 | 106.74 (REGN) |
| 2023-08-23 | 2023-08-21 | 2023-08-21 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 853.0 | 40.62 | 0.08 | 829.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1247.0 | 106.74 (REGN) |
| 2023-10-03 | 2023-09-29 | 2023-09-29 | 4 | Bassler Bonnie L | DIRECTOR | acq | 1384.0 | 3.06 | 0.03 | 27.08 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code A | 45169.0 | 448.93 (RPRX) |
| 2023-12-14 | 2023-12-13 | 2023-12-13 | 4 | Bassler Bonnie L | DIRECTOR | acq | 610.0 | 32.85 | 0.06 | 376.69 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 1857.0 | 107.13 (REGN) |
| 2023-12-14 | 2023-12-13 | 2023-12-13 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 610.0 | 32.85 | 0.06 | 870.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1247.0 | 107.13 (REGN) |
| 2023-12-29 | 2023-12-29 | 2023-12-29 | 4 | Bassler Bonnie L | DIRECTOR | acq | 1353.0 | 2.91 | 0.03 | 27.71 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code A | 46522.0 | 444.89 (RPRX) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 to 2024-01-03 | 4 | Bassler Bonnie L | DIRECTOR | acq | 961.0 | 43.52 | 0.09 | 327.43 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A M | 2208.0
|
107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-03 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 826.0 | 37.41 | 0.08 | 914.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1382.0 | 107.13 (REGN) |
| 2024-01-31 | 2024-01-30 | 2024-01-30 | 4 | Bassler Bonnie L | DIRECTOR | acq | 827.0 | 37.44 | 0.08 | 380.95 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 2209.0 | 107.13 (REGN) |
| 2024-01-31 | 2024-01-30 | 2024-01-30 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 827.0 | 37.44 | 0.08 | 959.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1382.0 | 107.13 (REGN) |
| 2024-02-26 | 2024-02-26 | 2024-02-26 | 4 | Bassler Bonnie L | DIRECTOR | acq | 854.0 | 38.19 | 0.08 | 391.92 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 2236.0 | 107.94 (REGN) |
| 2024-02-26 | 2024-02-26 | 2024-02-26 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 854.0 | 38.19 | 0.08 | 979.25 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1382.0 | 107.94 (REGN) |
| 2024-04-02 | 2024-03-28 | 2024-03-28 | 4 | Bassler Bonnie L | DIRECTOR | acq | 1240.0 | 2.6 | 0.03 | 30.23 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code A | 47762.0 | 446.69 (RPRX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-23 | 2023-06-22 | 2023-06-22 | 4 | Bassler Bonnie L | DIRECTOR | acq | 42500.0 | 100.0 | 4.72 | 1.17 | Direct | Stock Option (Right To Buy) | CIDARA THERAPEUTICS, INC. | code A | 42500.0 | 90.03 (CDTX) |
| 2023-08-11 | 2023-08-10 | 2023-08-10 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 853.0 | 33.32 | 0.08 | 391.92 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 1707.0 | 106.74 (REGN) |
| 2023-08-23 | 2023-08-21 | 2023-08-21 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 853.0 | 49.97 | 0.08 | 391.92 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 854.0 | 106.74 (REGN) |
| 2023-12-14 | 2023-12-13 | 2023-12-13 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 610.0 | 100.0 | 0.06 | 376.69 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-03 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 826.0 | 33.31 | 0.08 | 380.95 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 1654.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Bassler Bonnie L | DIRECTOR | acq | 1607.0 | 100.0 | 0.15 | 888.34 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 1607.0 | 107.13 (REGN) |
| 2024-01-31 | 2024-01-30 | 2024-01-30 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 827.0 | 50.0 | 0.08 | 380.95 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 827.0 | 107.13 (REGN) |
| 2024-02-26 | 2024-02-26 | 2024-02-26 | 4 | Bassler Bonnie L | DIRECTOR | dsp | 854.0 | 100.0 | 0.08 | 391.92 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.94 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)